Cargando…
The tumor suppressive role of CAMK2N1 in castration-resistant prostate cancer
Prostate cancer at advanced stages including metastatic and castration-resistant cancer remains incurable due to the lack of effective therapies. The CAMK2N1 gene, cloned and characterized as an inhibitor of CaMKII (calcium/calmodulin-dependent protein kinase II), has been shown to affect tumorigene...
Autores principales: | Wang, Tao, Liu, Zhuo, Guo, Shuiming, Wu, Licheng, Li, Mingchao, Yang, Jun, Chen, Ruibao, Xu, Hua, Cai, Shaoxin, Chen, Hui, Li, Weiyong, Wang, Liang, Hu, Zhiquan, Zhuang, Qianyuan, Xu, Shaohua, Wang, Liping, Liu, Jihong, Ye, Zhangqun, Ji, Jun-Yuan, Wang, Chenguang, Chen, Ke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116507/ https://www.ncbi.nlm.nih.gov/pubmed/25003983 |
Ejemplares similares
-
CAMK2N1 inhibits prostate cancer progression through androgen receptor-dependent signaling
por: Wang, Tao, et al.
Publicado: (2014) -
AR Pathway Is Involved in the Regulation of CX43 in Prostate Cancer
por: Chen, Ruibao, et al.
Publicado: (2015) -
AB225. The tumor suppressive role of CAMK2N1 in castration-resistant prostate cancer
por: Wang, T, et al.
Publicado: (2014) -
Clinical analysis of small cell carcinoma of the bladder in Chinese: nine case reports and literature reviews
por: Chen, Zhi, et al.
Publicado: (2017) -
Laparoscopic versus Open Radical Cystectomy in Bladder Cancer: A Systematic Review and Meta-Analysis of Comparative Studies
por: Tang, Kun, et al.
Publicado: (2014)